Target intelligence / Profile preview

LUC7 like 3 pre-mRNA splicing factor (LUC7L3)

Target
LUC7L3
Molecular classification
Other (RNA-binding protein; Splicing factor)
01

Overview

LUC7 like 3 pre-mRNA splicing factor (LUC7L3) is a nuclear RNA-binding protein involved in the regulation of pre-mRNA splicing. The protein contains an N-terminal region with cysteine/histidine motifs and leucine zipper-like repeats, and a C-terminal region rich in arginine-glutamate (RE domain) and arginine-serine (RS domain). It is a component of the spliceosome, particularly associated with the U1 small nuclear ribonucleoprotein (U1 snRNP) complex, and influences 5′ splice site recognition and alternative splicing outcomes. LUC7L3 exerts its regulatory function through direct RNA binding and interaction with other splicing factors; its loss or dysfunction can shift splicing patterns, affecting gene expression in a context-dependent manner. Disease associations include altered splicing in cancer and possible roles in cardiac disease via interaction with key splicing regulators such as RBM25. Two major isoforms result from alternative splicing of its transcript, but both are believed to encode the same protein.

Other names
CREAP-1CROPLUC7AOA48-18hLuc7ACRE-associated protein 1CRACisplatin resistance-associated-overexpressed proteinOkadaic acid-inducible phosphoprotein OA48-18cAMP regulatory element-associated protein 1
02

Biological functions

Pre-mRNA splicingAlternative splicing regulationRNA bindingcAMP response element DNA binding
03

Disease associations

Cancer (notably renal cell carcinoma with MIT translocations and TFEB-rearranged renal cell carcinoma)Potential implication in cardiac disease through splicing of SCN5A

Beyond the preview

Go deeper on LUC7 like 3 pre-mRNA splicing factor (LUC7L3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LUC7 like 3 pre-mRNA splicing factor (LUC7L3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call